ArticleCancer imaging : the official publication of the International Cancer Imaging Society2022

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib.

Osman Öcal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.